Board of Governors
The ACMA Board of Governors is responsible for ensuring all aspects of the company align with our global mission
Dr. Tania Small
M.D
Senior Vice President, Head of Medical Affairs at BMS
Michael H. Davidson
MD, FACC, FNLA
CEO New Amsterdam Pharma
Sotirios Stergiopoulos
MD, BCMAS, FACP
President & CEO at A2A Pharmaceuticals
Michael R. Ujhelyi
PharmD, FCCP
Managing Director at Npoint Sciences
Bob Oliver
MBA
Independent Director & Executive Advisor
Charles Stacey
MD, MBA
President and CEO at Cerecin
Ravi Tayi
MD, MPH
Chief Medical Officer at American Regent (a Daiichi Sankyo Company)
Jovan Reyerson
RN, MA
Senior Vice President, Global Medical & Scientific Affairs Strategy, Operations, Clinical Research at Olympus Corporation
Leona Blustein
PharmD, BCMAS
Senior Director, Head of US Medical Science Liaison Team at Idorsia Pharmaceuticals Ltd